Philipp Blanke, MD, a Jonathan R. Weir-McCall, MBCHB, PHD, b Stephan Achenbach, MD,
c Victoria Delgado, MD, PHD, d Jörg Hausleiter, MD, e Hasan Jilaihawi, MD, f Mohamed …

Minimally invasive strategies to treat valvular heart disease have emerged over the past 2
decades. The use of transcatheter aortic valve replacement in the treatment of severe aortic …

Transcatheter aortic valve implantation (TAVI) has emerged as an alternative less invasive
treatment for patients with symptomatic severe aortic stenosis. Despite the technological …

Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded
dramatically over the last years, thanks to the developments and improvements of devices …

Background: The transfemoral (TF) route is the gold-standard access for transcatheter aortic
valve replacement (TAVR). In 10–15% of patients, alternative accesses are needed, such as …

Aortic valve replacement has stood the test of time but is no longer an operation that is
exclusively approached through a median sternotomy using only sutured prostheses …

Transcarotid access has emerged as the preferred access site for transcatheter aortic valve
implantation (TAVI) in patients with prohibitive iliofemoral anatomy. This study aimed to …

Background Several predictors are available to guide patient selection for transcatheter
aortic valve replacement (TAVR) to achieve better outcomes, and cognitive function is one of …

OBJECTIVES The carotid approach for transcatheter aortic valve replacement (TAVR) has
been shown to be feasible and safe. The goal of this study was to compare the 30-day …

Background In patients who are not suitable for traditional access routes for transcatheter
aortic valve replacement (TAVR) due to severe peripheral vascular disease (PVD) or …